ΑΦΙΣΑ

Πατήστε εδώ για τη συνέντευξη

NEJM

“A Monoclonal Antibody to PACAP for Migraine Prevention”
Ashina et al
NEJM, September 4, 2024

Lancet

1. “Migraine: disease characterisation, biomarkers, and precision medicine”
   Ashina et al. The Lancet. March 25, 2021.
2. “Migraine: epidemiology and systems of care”
   Ashina et al. The Lancet. March 25, 2021.
3. “Migraine: integrated approaches to clinical management and emerging treatments”
   Ashina et al. The Lancet. March 25, 2021.

Nature Reviews Neurology

1. “Diagnosis and management of migraine in ten steps”
   Eigenbrodt A.K., Ashina H., Khan S., Diener H-C., Mitsikostas D.D., et al.
   Nat Rev Neurol (2021). https://doi.org/10.1038/s41582-021-00509-5

Nature Reviews Disease Primers

1. “Tension-type headache”
   Ashina, S., Mitsikostas, D.D., Lee, M.J. et al.
   Nat Rev Dis Primers 7, 24 (2021). https://doi.org/10.1038/s41572-021-00257-2.
   

Cephalalgia

1. “A population-based survey for disabling headaches in Greece: Prevalence, burden and treatment preferences”
   Constantinidis, T.S., Arvaniti, C., Fakas, N., Rudolf J., Kouremenos E., Giannouli E., Mitsikostas D.D.
   Cephalalgia 2021 Jun;41(7):810-820. doi: 10.1177/0333102421989630
2. “The prevalence and burden of medication overuse headache in Greece.”
   Constantinidis TS, Arvaniti C, Fakas N, Rudolf J, Kouremenos E, Giannouli E. and Mitsikostas DD, on behalf of the Hellenic Headache Society.
   Cephalalgia 2023, Vol. 43(6) 1–11. Doi: 10.1177/03331024231184909

European Journal of Neurology

1. "European Academy of Neurology guidelines on the treatment of cluster headache"
   May, A, Evers, S, Goadsby, PJ, et al.
   Eur J Neurol. 2023; 00: 1-25. doi:10.1111/ene.15956